Neoadjuvant, inductive or adjuvant chemotherapy of bladder cancer

被引：0

作者：

Ohlmann, C. -H. ^{[1
]}

De Santis, M. ^{[2
]}

机构：

[1] Univ Klinikum Saarlandes, Klin Urol & Kinderurol, D-66424 Homburg, Germany

[2] Kaiser Franz Josef Spital SMZ Sud, Med Abt 3, Zentrum Onkol & Hamatol & Angew Krebsforsch, Inst Translationale Forsch Wien ACR ITR VIEnna, Vienna, Austria

来源：

UROLOGE | 2013年 / 52卷 / 11期

关键词：

Cisplatin; Chemotherapy; perioperative; Cystectomy; Lymphadenectomy; Micrometastases; RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; PHASE-III; PROGNOSTIC VALUE; CISPLATIN; THERAPY; GEMCITABINE; SURVIVAL; TRIAL;

D O I：

10.1007/s00120-013-3249-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Perioperative chemotherapy is a standard treatment for patients with muscle-invasive bladder carcinoma undergoing radical cystectomy; however, direct comparisons of neoadjuvant and adjuvant chemotherapy are lacking. Evidence-based data and implementation into daily clinical practice favor neoadjuvant chemotherapy; nevertheless, neoadjuvant chemotherapy is still underused in daily practice compared to adjuvant chemotherapy. If neoadjuvant chemotherapy has not been used and patients are fit enough to receive cisplatin, adjuvant chemotherapy should be considered in patients with pT3-pT4 and/or lymph node metastases.

引用

页码：1534 / +

页数：6

共 33 条

[1] Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
Abol-Enein, H
Bassi, P
Boyer, M
Coppin, CML
Cortesi, E
Grossman, HB
Hall, RR
Horwich, A
Malmström, PU
Martinez-Piñeiro, JA
Sengelov, L
Sherif, A
Wallace, DMA
Bono, AV
Goebell, PJ
Groshen, S
Torti, FM
Clarke, NW
Roberts, JT
Sylvester, R
Parmar, MKB
Stewart, LA
Tierney, JF
Vale, CL
[J]. EUROPEAN UROLOGY, 2005, 48 (02) : 202 - 206
[2] Abol-Enein H, 2003, LANCET, V361, P1927
[3] [Anonymous], 1999, Lancet, V354, P533
[4] [Anonymous], J CLIN ONCOL S
[5] Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bellmunt, J.
Orsola, A.
Wiegel, T.
Guix, M.
De Santis, M.
Kataja, V.
[J]. ANNALS OF ONCOLOGY, 2011, 22 : vi45 - vi49
[6] Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data
Bono, AV
Goebell, PJ
Groshen, S
Lehmann, J
Studer, U
Torti, FM
Abol-Enein, H
Bassi, P
Boyer, M
Coppin, CML
Cortesi, E
Hall, RR
Horwich, A
Malmström, PU
Martínez-Piñeiro, JA
Sengelov, L
Sherif, A
Wallace, DMA
Clarke, NW
Roberts, JT
Sylvester, R
Parmar, MKB
Stewart, LA
Tierney, JF
Vale, CL
[J]. EUROPEAN UROLOGY, 2005, 48 (02) : 189 - 201
[7] Clinical Outcomes and Recurrence Predictors of Lymph Node Positive Urothelial Cancer After Cystectomy
Bruins, Harman M.
Huang, George J.
Cai, Jie
Skinner, Donald G.
Stein, John P.
Penson, David F.
[J]. JOURNAL OF UROLOGY, 2009, 182 (05) : 2182 - 2187
[8] Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire
Burger, Maximilian
Mulders, Peter
Witjes, Wim
[J]. EUROPEAN UROLOGY, 2012, 61 (05) : 1070 - 1071
[9] Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
Chromecki, Thomas F.
Mauermann, Julian
Cha, Eugene K.
Svatek, Robert S.
Fajkovic, Harun
Karakiewicz, Pierre I.
Lotan, Yair
Tilki, Derya
Bastian, Patrick J.
Volkmer, Bjoern G.
Montorsi, Francesco
Kassouf, Wassim
Novara, Giacomo
Fritsche, Hans-Martin
Ficarra, Vincenzo
Stief, Christian G.
Dinney, Colin P.
Skinner, Eila
Pummer, Karl
Fradet, Yves
Shariat, Shahrokh F.
[J]. WORLD JOURNAL OF UROLOGY, 2012, 30 (06) : 753 - 759
[10] Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial
Cognetti, F.
Ruggeri, E. M.
Felici, A.
Gallucci, M.
Muto, G.
Pollera, C. F.
Massidda, B.
Rubagotti, A.
Giannarelli, D.
Boccardo, F.
[J]. ANNALS OF ONCOLOGY, 2012, 23 (03) : 695 - 700

← 1 2 3 4 →